Isturisa Interactions
There are 594 drugs known to interact with Isturisa (osilodrostat), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 109 are major, 464 are moderate, and 21 are minor.
- View all 594 medications that may interact with Isturisa
- View Isturisa alcohol/food interactions (1)
- View Isturisa disease interactions (4)
Most frequently checked interactions
View interaction reports for Isturisa (osilodrostat) and the medicines listed below.
- Actemra (tocilizumab)
- Andembry (garadacimab)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Blincyto (blinatumomab)
- Caplyta (lumateperone)
- celecoxib
- cyclobenzaprine
- Cymbalta (duloxetine)
- Emgality (galcanezumab)
- Entresto (sacubitril / valsartan)
- Esbriet (pirfenidone)
- Evrysdi (risdiplam)
- Farxiga (dapagliflozin)
- Fintepla (fenfluramine)
- furosemide
- gabapentin
- Hemlibra (emicizumab)
- hydrocortisone
- Jardiance (empagliflozin)
- Kesimpta (ofatumumab)
- Kevzara (sarilumab)
- Kyprolis (carfilzomib)
- losartan
- Luxturna (voretigene neparvovec ophthalmic)
- Mayzent (siponimod)
- metformin
- methotrexate
- montelukast
- Mounjaro (tirzepatide)
Isturisa alcohol/food interactions
There is 1 alcohol/food interaction with Isturisa (osilodrostat).
Isturisa disease interactions
There are 4 disease interactions with Isturisa (osilodrostat) which include:
Report options
QR code containing a link to this page
More about Isturisa (osilodrostat)
- Isturisa consumer information
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: adrenal corticosteroid inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.